Showing results (471-480 of 693) with videos related to

Sort By:
Pageof 70
Leukemia|May 1, 1997
Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukaemia effectF Locatelli, P Comoli, G Giorgiani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 21, 2007
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patientsV Brazzelli, F Prestinari, T Barbagallo, et al.
Bone Marrow Transplantation|August 26, 1998
Cord blood transplantation for children with acute leukemia. Eurocord Transplant GroupF Locatelli, V Rocha, C Chastang, et al.
Journal of Endocrinological Investigation|June 6, 2009
Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndromeA Salvatoni, E Veronelli, L Nosetti, et al.
Acta Anaesthesiologica Scandinavica|November 15, 2007
Time- and dose-related regional fluxes of tissue-type plasminogen activator in anesthetized endotoxemic pigsA Nyberg, S M Jakob, H Seeman-Lodding, et al.
Bone Marrow Transplantation|April 1, 1999
Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo OsseoA Messori, A Bosi, S Bacci, et al.
Arthritis and Rheumatism|April 22, 1999
Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosisA Martini, R Maccario, A Ravelli, et al.
Haematologica|January 1, 1992
Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias"R Invernizzi, C Rosanda, G Basso, et al.
Medical and Pediatric Oncology|March 1, 1995
Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantationM Zecca, V Rosti, L Pinto, et al.
Journal of Human Hypertension|May 20, 2006
Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trialG L Bakris, L Ruilope, F Locatelli, et al.
Pageof 70